JAK2 and myeloproliferative neoplasm: In this set of experiments we analyzed if an MPN cell line (UKE-1 and SET-2) with the mutation in JAK2 can change the expression of important key genes, important in the hematopoiesis maintenance, in two different healthy mesenchymal cell lines (hTERT and HS5).